Contact UsInvestorsCareersMediaScienceContact Us

PAXLOVID (nirmatrelvir tablets; ritonavir tablets)

Product Information

Product Monograph (download PDF, 732KB)

Patient Information (download PDF, 352KB)

Product CommunicationJanuary 17, 2022 Important Safety Information on PAXLOVID (nirmatrelvir and ritonavir) [Download PDF 203kb]July 6, 2022 Important Safety Information on Paxlovid (nirmatrelvir and ritonavir) [Download PDF 402kb]

Canadian regulations limit the scope of information we are permitted to give on prescription drugs via the Internet or other means. Please consult a qualified health professional for more detailed information.

Please contact Pfizer Canada Medical Information at 1 800 463-6001 with any comments or inquiries.

If you encounter technical difficulties in viewing our product information please contact Pfizer.ca

About UsOur ProductsHelping Communities Our Voice Suppliers Distribution ChannelPfizer WorldwideMedia CentreTerms Of Use Careers Healthcare ProfessionalsContact UsPrivacy PolicyCopyright © Pfizer Canada 2022 All rights reserved. The information is intended only for residents of Canada. ® Pfizer Inc, used under license